Anti-Painkiller Abuse Bill Might Inflate Cost Of Generics

By Greg Ryan (July 19, 2012, 8:57 PM EDT) -- A bipartisan bill introduced Thursday to require drug companies to make prescription painkillers tamper-resistant, part of a recent push to curtail abuse of the drugs, could drive up the cost of generic drugs by forcing generics makers to license anti-tampering intellectual property or develop their own, experts say.

The Stop Tampering of Prescription Pills Act of 2012, or STOPP Act, introduced by Reps. Bill Keating, D-Mass., and Mary Bono Mack, R-Calif., would mandate that drugmakers manufacture opioids to be resistant to crushing or otherwise made more likely to be abused. If a company fails to do so, the U.S. Food and...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!